Children with relapsed or refractory nephroblastoma : favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation
- Alternative title
-
Vorteilhaftes Langzeitüberleben von Kindern mit rezidivierten Nephroblastomen nach Hochdosis-Chemotherapie und autologem Stammzellrescue
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Klinische Pädiatrie, 226.2014, Heft 6-7, S. 351-356, doi:10.1055/s-0034-1390504
- Keyword
-
Pädiatrie
Kinderkrankheit
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2014
- Creator
- URN
-
urn:nbn:de:hebis:30:3-358097
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Illhardt, Toni
- Ebinger, Martin
- Schwarze, Carl Philipp
- Feuchtinger, Tobias F.
- Furtwängler, Rhoikos
- Schlegel, Paul-Gerhardt
- Klingebiel, Thomas
- Greil, Johann
- Beck, James F.
- Handgretinger, Rupert
- Lang, Peter
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2014
Other Objects (12)
Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in relapsed or refractory primary CNS lymphoma : a retrospective monocentric analysis of long-term outcome, prognostic factors, and toxicity
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Management of relapsed-refractory diffuse large B cell lymphoma
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in relapsed or refractory primary CNS lymphoma : a retrospective monocentric analysis of long-term outcome, prognostic factors, and toxicity
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Management of relapsed-refractory diffuse large B cell lymphoma
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in relapsed or refractory primary CNS lymphoma : a retrospective monocentric analysis of long-term outcome, prognostic factors, and toxicity
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Management of relapsed-refractory diffuse large B cell lymphoma